- Home
- FNWB vs HLVX Comparison
FNWB vs HLVX Comparison
Compare FNWB & HLVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FNWB
- HLVX
- Stock Information
- Founded
- FNWB 1923
- HLVX 2020
- Country
- FNWB United States
- HLVX United States
- Employees
- FNWB N/A
- HLVX N/A
- Industry
- FNWB Banks
- HLVX Biotechnology: Pharmaceutical Preparations
- Sector
- FNWB Finance
- HLVX Health Care
- Exchange
- FNWB Nasdaq
- HLVX Nasdaq
- Market Cap
- FNWB 89.9M
- HLVX 93.1M
- IPO Year
- FNWB 2015
- HLVX 2022
- Fundamental
- Price
- FNWB $10.93
- HLVX $1.88
- Analyst Decision
- FNWB Hold
- HLVX Hold
- Analyst Count
- FNWB 1
- HLVX 5
- Target Price
- FNWB $12.00
- HLVX $2.33
- AVG Volume (30 Days)
- FNWB 14.1K
- HLVX 194.1K
- Earning Date
- FNWB 01-29-2025
- HLVX 03-19-2025
- Dividend Yield
- FNWB 2.56%
- HLVX N/A
- EPS Growth
- FNWB N/A
- HLVX N/A
- EPS
- FNWB N/A
- HLVX N/A
- Revenue
- FNWB $50,900,000.00
- HLVX N/A
- Revenue This Year
- FNWB N/A
- HLVX N/A
- Revenue Next Year
- FNWB $12.62
- HLVX N/A
- P/E Ratio
- FNWB N/A
- HLVX N/A
- Revenue Growth
- FNWB N/A
- HLVX N/A
- 52 Week Low
- FNWB $8.91
- HLVX $1.55
- 52 Week High
- FNWB $16.00
- HLVX $20.22
- Technical
- Relative Strength Index (RSI)
- FNWB 59.87
- HLVX 43.15
- Support Level
- FNWB $10.55
- HLVX $1.92
- Resistance Level
- FNWB $10.96
- HLVX $2.00
- Average True Range (ATR)
- FNWB 0.24
- HLVX 0.07
- MACD
- FNWB 0.04
- HLVX -0.01
- Stochastic Oscillator
- FNWB 75.90
- HLVX 18.07
About FNWB First Northwest Bancorp
First Northwest Bancorp is a bank holding company and a financial holding company and is engaged in banking activities through its wholly owned subsidiary, First Fed Bank, as well as certain non-banking financial activities. It includes deposit and lending transactions that are supplemented with other borrowing and investing activities. The bank's principal lending activities are focused on first lien one- to four-family mortgage loans, commercial and multi-family real estate loans, construction and land loans, commercial business loans, and consumer loans.
About HLVX HilleVax Inc.
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.